Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glycoproteins | 7 | 2018 | 2201 | 1.540 |
Why?
|
| Proteome | 6 | 2022 | 1894 | 1.440 |
Why?
|
| Proteomics | 11 | 2020 | 3914 | 1.180 |
Why?
|
| Cysteine | 5 | 2023 | 896 | 0.790 |
Why?
|
| Glycosylation | 8 | 2018 | 1099 | 0.730 |
Why?
|
| Adipose Tissue, Brown | 3 | 2024 | 776 | 0.700 |
Why?
|
| Dendrimers | 1 | 2018 | 72 | 0.590 |
Why?
|
| Succinic Acid | 3 | 2024 | 86 | 0.560 |
Why?
|
| Tunicamycin | 2 | 2016 | 108 | 0.550 |
Why?
|
| Mass Spectrometry | 7 | 2020 | 2198 | 0.520 |
Why?
|
| Acetylglucosamine | 1 | 2017 | 188 | 0.500 |
Why?
|
| Polysaccharides | 2 | 2018 | 1020 | 0.470 |
Why?
|
| Nanotubes | 3 | 2017 | 83 | 0.400 |
Why?
|
| Thermogenesis | 4 | 2022 | 495 | 0.350 |
Why?
|
| Phototherapy | 3 | 2017 | 368 | 0.330 |
Why?
|
| Liver | 2 | 2016 | 7571 | 0.330 |
Why?
|
| Gold | 3 | 2017 | 480 | 0.320 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2016 | 2678 | 0.310 |
Why?
|
| Anticholesteremic Agents | 1 | 2015 | 970 | 0.290 |
Why?
|
| Membrane Glycoproteins | 1 | 2018 | 3702 | 0.290 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 2 | 2018 | 138 | 0.280 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2016 | 1836 | 0.270 |
Why?
|
| Glycopeptides | 2 | 2017 | 225 | 0.250 |
Why?
|
| Proteins | 1 | 2020 | 6002 | 0.240 |
Why?
|
| Hep G2 Cells | 2 | 2016 | 378 | 0.230 |
Why?
|
| Aging | 2 | 2020 | 8731 | 0.230 |
Why?
|
| Boronic Acids | 2 | 2018 | 915 | 0.220 |
Why?
|
| Saposins | 1 | 2023 | 22 | 0.210 |
Why?
|
| Adipocytes, Brown | 1 | 2024 | 160 | 0.210 |
Why?
|
| Extracellular Fluid | 1 | 2023 | 165 | 0.190 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3250 | 0.180 |
Why?
|
| Creatine Kinase | 1 | 2023 | 683 | 0.180 |
Why?
|
| Creatine | 1 | 2023 | 424 | 0.180 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2021 | 145 | 0.170 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2018 | 1964 | 0.170 |
Why?
|
| Jurkat Cells | 2 | 2018 | 740 | 0.160 |
Why?
|
| Hypothermia | 1 | 2021 | 189 | 0.160 |
Why?
|
| Hepatitis | 1 | 2021 | 226 | 0.160 |
Why?
|
| Isotope Labeling | 2 | 2017 | 390 | 0.160 |
Why?
|
| Organ Specificity | 2 | 2020 | 1966 | 0.150 |
Why?
|
| Click Chemistry | 1 | 2018 | 100 | 0.150 |
Why?
|
| Lactic Acid | 1 | 2023 | 1139 | 0.140 |
Why?
|
| Inflammasomes | 1 | 2023 | 541 | 0.140 |
Why?
|
| Oxidation-Reduction | 2 | 2023 | 2221 | 0.140 |
Why?
|
| Glycolysis | 1 | 2021 | 838 | 0.140 |
Why?
|
| Hyperthermia, Induced | 2 | 2017 | 414 | 0.130 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2021 | 1245 | 0.130 |
Why?
|
| Mice | 10 | 2024 | 81889 | 0.130 |
Why?
|
| Reactive Oxygen Species | 2 | 2023 | 2142 | 0.130 |
Why?
|
| Molecular Conformation | 1 | 2017 | 540 | 0.130 |
Why?
|
| Databases, Protein | 1 | 2017 | 390 | 0.120 |
Why?
|
| Adipose Tissue | 3 | 2023 | 3314 | 0.120 |
Why?
|
| Phenylalanine | 1 | 2016 | 367 | 0.120 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2017 | 393 | 0.120 |
Why?
|
| Cell Cycle | 1 | 2023 | 2926 | 0.120 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2016 | 250 | 0.120 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1791 | 0.110 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2017 | 1197 | 0.110 |
Why?
|
| Quality Control | 1 | 2017 | 834 | 0.110 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2016 | 496 | 0.110 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2017 | 1528 | 0.110 |
Why?
|
| Lasers | 1 | 2017 | 951 | 0.100 |
Why?
|
| Integrins | 1 | 2017 | 839 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2023 | 2885 | 0.100 |
Why?
|
| Adiposity | 1 | 2022 | 1892 | 0.100 |
Why?
|
| Fungal Proteins | 1 | 2016 | 901 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 2 | 2017 | 6104 | 0.100 |
Why?
|
| Cytoskeleton | 1 | 2017 | 1179 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 22352 | 0.100 |
Why?
|
| Animals | 11 | 2024 | 168930 | 0.100 |
Why?
|
| Cell Survival | 2 | 2018 | 5748 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2023 | 3439 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2017 | 2717 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2022 | 4522 | 0.090 |
Why?
|
| Obesity | 2 | 2022 | 13090 | 0.080 |
Why?
|
| Peptides | 2 | 2020 | 4344 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2018 | 4276 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2020 | 3139 | 0.080 |
Why?
|
| Bone Marrow | 1 | 2018 | 2926 | 0.080 |
Why?
|
| Humans | 18 | 2023 | 766766 | 0.070 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2018 | 1663 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2016 | 13411 | 0.070 |
Why?
|
| Metabolomics | 1 | 2016 | 1675 | 0.070 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2021 | 800 | 0.060 |
Why?
|
| Cytokines | 1 | 2021 | 7438 | 0.060 |
Why?
|
| Software | 1 | 2020 | 4466 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2020 | 4970 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2017 | 4049 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 11920 | 0.050 |
Why?
|
| Anaphase | 1 | 2023 | 112 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14652 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2017 | 2929 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2017 | 12791 | 0.050 |
Why?
|
| Phosphotransferases | 1 | 2023 | 302 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2017 | 3792 | 0.050 |
Why?
|
| Adipokines | 1 | 2023 | 308 | 0.040 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2020 | 81 | 0.040 |
Why?
|
| Succinates | 1 | 2020 | 83 | 0.040 |
Why?
|
| Ovarian Neoplasms | 1 | 2017 | 4904 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2020 | 23619 | 0.040 |
Why?
|
| Ubiquitins | 1 | 2021 | 365 | 0.040 |
Why?
|
| Biological Transport | 1 | 2024 | 2083 | 0.040 |
Why?
|
| Extracellular Space | 1 | 2021 | 563 | 0.040 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 13 | 1 | 2018 | 40 | 0.040 |
Why?
|
| Antibody-Producing Cells | 1 | 2018 | 140 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2024 | 1029 | 0.040 |
Why?
|
| Adipose Tissue, White | 1 | 2021 | 371 | 0.040 |
Why?
|
| Iodoacetamide | 1 | 2017 | 33 | 0.040 |
Why?
|
| Ethylmaleimide | 1 | 2017 | 69 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2023 | 1716 | 0.040 |
Why?
|
| Muscles | 1 | 2023 | 1576 | 0.040 |
Why?
|
| Alkylation | 1 | 2017 | 84 | 0.040 |
Why?
|
| Neoplasms | 2 | 2017 | 22350 | 0.040 |
Why?
|
| Mitosis | 1 | 2023 | 1176 | 0.040 |
Why?
|
| Symporters | 1 | 2020 | 362 | 0.040 |
Why?
|
| Acrylamide | 1 | 2017 | 59 | 0.040 |
Why?
|
| 14-3-3 Proteins | 1 | 2018 | 221 | 0.040 |
Why?
|
| Acetylgalactosamine | 1 | 2017 | 41 | 0.040 |
Why?
|
| Acylation | 1 | 2017 | 98 | 0.040 |
Why?
|
| Glucose Intolerance | 1 | 2021 | 578 | 0.030 |
Why?
|
| Inflammation | 3 | 2021 | 10860 | 0.030 |
Why?
|
| Actomyosin | 1 | 2017 | 112 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2020 | 2478 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 2020 | 1208 | 0.030 |
Why?
|
| Disulfides | 1 | 2017 | 462 | 0.030 |
Why?
|
| Fibronectins | 1 | 2018 | 722 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2020 | 938 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 526 | 0.030 |
Why?
|
| Surface Properties | 1 | 2016 | 1153 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 996 | 0.030 |
Why?
|
| Ovary | 1 | 2017 | 963 | 0.030 |
Why?
|
| Particle Size | 1 | 2016 | 1634 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2016 | 1211 | 0.020 |
Why?
|
| Mouth Neoplasms | 1 | 2017 | 595 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2017 | 1325 | 0.020 |
Why?
|
| Cell Death | 1 | 2016 | 1676 | 0.020 |
Why?
|
| Brain | 1 | 2018 | 27159 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2023 | 3601 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2017 | 3093 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2017 | 3616 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2021 | 2903 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 17088 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2017 | 2093 | 0.020 |
Why?
|
| Glucose | 1 | 2021 | 4340 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 3609 | 0.020 |
Why?
|
| RNA Interference | 1 | 2017 | 2827 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3607 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 6222 | 0.020 |
Why?
|
| Mitochondria | 1 | 2020 | 3677 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 4891 | 0.020 |
Why?
|
| Protein Binding | 1 | 2018 | 9320 | 0.020 |
Why?
|
| Pyridines | 1 | 2017 | 2888 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 14471 | 0.020 |
Why?
|
| Computational Biology | 1 | 2017 | 3564 | 0.020 |
Why?
|
| Cell Movement | 1 | 2017 | 5199 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8540 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 18984 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 11218 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9525 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 8621 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2017 | 10445 | 0.010 |
Why?
|
| Apoptosis | 1 | 2017 | 9513 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13640 | 0.010 |
Why?
|
| Female | 4 | 2021 | 396520 | 0.010 |
Why?
|
| Male | 3 | 2024 | 364142 | 0.010 |
Why?
|
| Time Factors | 1 | 2016 | 40149 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 13643 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 59939 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 223257 | 0.000 |
Why?
|
| Adult | 1 | 2018 | 223307 | 0.000 |
Why?
|
Concepts
(170)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(35)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore